US Patent Issued to Biosion on Nov. 25 for "Monoclonal antibodies which bind thymic stromal lymphopoietin (TSLP), encoding polynucleotides thereof and methods of use thereof to treat diseases" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,912, issued on Nov. 25, was assigned to Biosion Inc. (Jiangsu, China).

"Monoclonal antibodies which bind thymic stromal lymphopoietin (TSLP), encoding polynucleotides thereof and methods of use thereof to treat diseases" was invented by Mingjiu Chen (Nanjing, China), Wei Tan (Nanjing, China), Cathy Xiaoyan Zhong (Nanjing, China), Zhengping Zhang (Lianyungang, China), Xiaofang Zou (Lianyungang, China), Wei Song (Lianyungang, China) and Hongjiang Xu (Lianyungang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is an isolated monoclonal antibody that specifically binds human TSLP, or the antigen-binding portion thereof. A nucleic acid mo...